Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/4/2019
SIETES contiene 92718 citas

 
 
 1 a 20 de 116 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Broekhuijsen K, van Baaren G-J, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KWM, Scheepers CJ, Bremer HA, Rijnders RJP, van Loon AJ, Perquin DAM, Sporken JMJ, Papatsonis DNM, van Huizen ME, Vredevoogd CB, Brons JTJ, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BWJ, Franssen MTM, Langenveld J, HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015;385:2492-501. [Ref.ID 99304]
2.Tiene citas relacionadas Cita con resumen
Trotta F, Da Cas R, Alegiani SS, Gramegna M, Venegoni M, Zocchetti C, Traversa G. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ 2014;348:g3361. [Ref.ID 98028]
3.Tiene citas relacionadas
Fell DB, Dodds L, McNeil S, MacDonald NE. H1N1 influenza vaccination during pregnancy. BMJ 2014;348:g3500. [Ref.ID 98025]
4. Cita con resumen
Anónimo. Low-dose aspirin for prevention of preeclampsia. Med Lett Drugs Ther 2014;56:49. [Ref.ID 97920]
5.Enlace a cita original Cita con resumen
Anónimo. Venlafaxine, pre-eclampsia, eclampsia and related disorders of pregnancy. Introduction. WHO Pharmaceuticals Newsletter 2012;1:19. [Ref.ID 92208]
6. Cita con resumen
Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Godines M, Parry S, Macones G, Strauss JF. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 2011;342:d2901. [Ref.ID 90726]
7. Cita con resumen
Buppasiri P, Lumbiganon P, Thinkhamrop J, Ngamjarus C, Laopaiboon M. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes. Cochrane Database Systematic Review 2011:7079. [Ref.ID 90506]
8.Tiene citas relacionadas
von Dadelszen P, Payne B, Li J, Ansermino JM, Pipkin FB, Côté A-M, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin J-M, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA, for the PIERS Study Group. Prediction of advese maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377:219-27. [Ref.ID 90076]
9.Tiene citas relacionadas
Teela KC, Ferguson RM, Donnay FA, Darmstadt GL. The PIERS trial: hope for averting deaths from pre-eclampsia. Lancet 2011;377:185-6. [Ref.ID 90075]
10.Enlace a cita original Cita con resumen
Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S, on behal of the Guideline Development Group. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 2010;341:499-502. [Ref.ID 89344]
12.
Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631-44. [Ref.ID 89175]
13.Tiene citas relacionadas Cita con resumen
McCance DR, Holmes VA, Maresh MJA, Patterson CC, Walker JD, Pearson DWM, Young IS, for the Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010;376:259-66. [Ref.ID 88923]
14.Tiene citas relacionadas
Sibai BM. Vitamin C and E to prevent pre-eclampsia in diabetic women. Lancet 2010;376:214-6. [Ref.ID 88916]
15.Tiene citas relacionadas
Sacks DA. Gestational diabetes - Whom do we treat?. N Engl J Med 2009;361:1396-8. [Ref.ID 86880]
16.Tiene citas relacionadas
Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp Jr JM, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339-48. [Ref.ID 86879]
17.Tiene citas relacionadas Cita con resumen
Koopmans CM, Bijlenga D, Groen H, Vijgen SMC, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KWM, Drogtrop AP, Franx A, de Groot CJM, Huisjes AJM, Kwee A, van Loon AJ, Lub A, Papatsonis DNM, van der Post JAM, Roumen FJME, Scheepers HCJ, Willekes C, Mol BWJ, van Pampus MG, for the HYPITAT study group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks's gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009;374:979-88. [Ref.ID 86837]
18.Tiene citas relacionadas Cita con resumen
Johnson DD. Induced labour for pre-eclampsia and gestational hypertension. Lancet 2009;374:951-2. [Ref.ID 86835]
19.
Langer A, Villar J, Tell K, Kim T, Kennedy S. Reducing eclampsia-related deaths - a call to action. Lancet 2008;371:705-6. [Ref.ID 82265]
20.Enlace a cita original
Serrano NC, Díez LA, Páez MC, Mesa CM, Cifuentes R, et al.. Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of samll-study bias. PLOS Medicine 2006;3:520. [Ref.ID 78889]
Seleccionar todas
 
 1 a 20 de 116 siguiente >>